|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/50 | (2006.01) |
| A61K 9/1652 | (2013.01) | ||
| A61K 38/17 | (2006.01) | ||
| A61K 9/1647 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61K 38/179 | (2013.01) | ||
| A61K 9/16 | (2006.01) | ||
| A61K 9/1641 | (2013.01) | ||
| A61K 9/5047 | (2013.01) | ||
| A61K 9/1623 | (2013.01) | ||
| A61K 9/5031 | (2013.01) |
| (11) | Number of the document | 3574897 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19180351.9 |
| Date of filing the European patent application | 2012-11-18 | |
| (97) | Date of publication of the European application | 2019-12-04 |
| (45) | Date of publication and mention of the grant of the patent | 2022-01-05 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201161561525 P | 2011-11-18 | US |
| (72) |
CHEN, Hunter , US
WALSH, Scott , US
|
| (73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (54) | EXTENDED RELEASE FORMULATION COMPRISING POLYMER PROTEIN MICROPARTICLES FOR USE IN THE VITREOUS OF THE EYE FOR TREATING VASCULAR EYE DISORDERS |
| EXTENDED RELEASE FORMULATION COMPRISING POLYMER PROTEIN MICROPARTICLES FOR USE IN THE VITREOUS OF THE EYE FOR TREATING VASCULAR EYE DISORDERS |